BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 23223448)

  • 1. Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer.
    Esser AK; Miller MR; Huang Q; Meier MM; Beltran-Valero de Bernabé D; Stipp CS; Campbell KP; Lynch CF; Smith BJ; Cohen MB; Henry MD
    J Biol Chem; 2013 Jan; 288(4):2132-42. PubMed ID: 23223448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycosyltransferase LARGE2 is repressed by Snail and ZEB1 in prostate cancer.
    Huang Q; Miller MR; Schappet J; Henry MD
    Cancer Biol Ther; 2015; 16(1):125-36. PubMed ID: 25455932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer.
    Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P
    Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of dystroglycan glycosyltransferases LARGE2 and ISPD associate with increased mortality in clear cell renal cell carcinoma.
    Miller MR; Ma D; Schappet J; Breheny P; Mott SL; Bannick N; Askeland E; Brown J; Henry MD
    Mol Cancer; 2015 Jul; 14():141. PubMed ID: 26220087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
    Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
    Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer.
    Shimojo H; Kobayashi M; Kamigaito T; Shimojo Y; Fukuda M; Nakayama J
    Prostate; 2011 Aug; 71(11):1151-7. PubMed ID: 21656825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LARGE2-dependent glycosylation confers laminin-binding ability on proteoglycans.
    Inamori KI; Beedle AM; de Bernabé DB; Wright ME; Campbell KP
    Glycobiology; 2016 Dec; 26(12):1284-1296. PubMed ID: 27496765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Dystroglycan hypoglycosylation affects cell migration by influencing β-dystroglycan membrane clustering and filopodia length: A multiscale confocal microscopy analysis.
    Palmieri V; Bozzi M; Signorino G; Papi M; De Spirito M; Brancaccio A; Maulucci G; Sciandra F
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2182-2191. PubMed ID: 28572004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fer kinase regulates cell migration through α-dystroglycan glycosylation.
    Yoneyama T; Angata K; Bao X; Courtneidge S; Chanda SK; Fukuda M
    Mol Biol Cell; 2012 Mar; 23(5):771-80. PubMed ID: 22238358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase.
    Bao X; Kobayashi M; Hatakeyama S; Angata K; Gullberg D; Nakayama J; Fukuda MN; Fukuda M
    Proc Natl Acad Sci U S A; 2009 Jul; 106(29):12109-14. PubMed ID: 19587235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of alpha-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE.
    de Bernabé DB; Inamori K; Yoshida-Moriguchi T; Weydert CJ; Harper HA; Willer T; Henry MD; Campbell KP
    J Biol Chem; 2009 Apr; 284(17):11279-84. PubMed ID: 19244252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2.
    Inamori K; Hara Y; Willer T; Anderson ME; Zhu Z; Yoshida-Moriguchi T; Campbell KP
    Glycobiology; 2013 Mar; 23(3):295-302. PubMed ID: 23125099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of deregulated like-acetylglucosaminyl transferase and aberrant α-dystroglycan expression with human tongue cancer metastasis.
    Zhang HZ; Xia XY; Zhu F; Shen H; Song K; Shang ZJ
    J Oral Maxillofac Surg; 2014 Jun; 72(6):1106-18. PubMed ID: 24629698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-silico structural analysis of E509K mutation in LARGE and T192M mutation in Alpha Dystroglycan in the inhibition of glycosylation of Alpha Dystroglycan by LARGE.
    Bhattacharya S; Das A; Bagchi A
    Comput Biol Chem; 2016 Oct; 64():313-321. PubMed ID: 27565399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exogenous expression of the glycosyltransferase LARGE1 restores α-dystroglycan matriglycan and laminin binding in rhabdomyosarcoma.
    Beltrán D; Anderson ME; Bharathy N; Settelmeyer TP; Svalina MN; Bajwa Z; Shern JF; Gultekin SH; Cuellar MA; Yonekawa T; Keller C; Campbell KP
    Skelet Muscle; 2019 May; 9(1):11. PubMed ID: 31054580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A role of fukutin, a gene responsible for Fukuyama type congenital muscular dystrophy, in cancer cells: a possible role to suppress cell proliferation.
    Yamamoto T; Kato Y; Shibata N; Sawada T; Osawa M; Kobayashi M
    Int J Exp Pathol; 2008 Oct; 89(5):332-41. PubMed ID: 18808525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LARGE2 facilitates the maturation of alpha-dystroglycan more effectively than LARGE.
    Fujimura K; Sawaki H; Sakai T; Hiruma T; Nakanishi N; Sato T; Ohkura T; Narimatsu H
    Biochem Biophys Res Commun; 2005 Apr; 329(3):1162-71. PubMed ID: 15752776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Missense mutations in β-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) cause Walker-Warburg syndrome.
    Buysse K; Riemersma M; Powell G; van Reeuwijk J; Chitayat D; Roscioli T; Kamsteeg EJ; van den Elzen C; van Beusekom E; Blaser S; Babul-Hirji R; Halliday W; Wright GJ; Stemple DL; Lin YY; Lefeber DJ; van Bokhoven H
    Hum Mol Genet; 2013 May; 22(9):1746-54. PubMed ID: 23359570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.